Stuart A. Becker

435 total citations
12 papers, 353 citations indexed

About

Stuart A. Becker is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Stuart A. Becker has authored 12 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Genetics and 5 papers in Surgery. Recurrent topics in Stuart A. Becker's work include Microscopic Colitis (7 papers), Inflammatory Bowel Disease (6 papers) and Systemic Lupus Erythematosus Research (2 papers). Stuart A. Becker is often cited by papers focused on Microscopic Colitis (7 papers), Inflammatory Bowel Disease (6 papers) and Systemic Lupus Erythematosus Research (2 papers). Stuart A. Becker collaborates with scholars based in Israel and United States. Stuart A. Becker's co-authors include Diane R. Mould, Iris Dotan, Sigal Fishman, Lior Yahav, Yulia Ron, Henit Yanai, A Eliraz, Yoram Bujanover, Arnon Lavie and Nadir Arber and has published in prestigious journals such as The Lancet, Gastroenterology and Digestive Diseases and Sciences.

In The Last Decade

Stuart A. Becker

12 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart A. Becker Israel	7	254	222	101	91	33	12	353
S Bar-Meir Israel	5	193 0.8×	147 0.7×	111 1.1×	68 0.7×	23 0.7×	11	345
Ignace Dalle Belgium	7	178 0.7×	193 0.9×	60 0.6×	132 1.5×	39 1.2×	14	410
A M van der Wal Netherlands	10	138 0.5×	84 0.4×	65 0.6×	112 1.2×	53 1.6×	13	336
Arnold Stronkhorst Netherlands	9	157 0.6×	91 0.4×	77 0.8×	100 1.1×	25 0.8×	22	310
Kamila Stawczyk‐Eder Poland	13	274 1.1×	170 0.8×	73 0.7×	127 1.4×	19 0.6×	40	396
M. Ascolani Italy	10	234 0.9×	154 0.7×	63 0.6×	126 1.4×	30 0.9×	20	323
Hiroaki Matake Japan	10	260 1.0×	243 1.1×	52 0.5×	165 1.8×	46 1.4×	18	403
Justin Côté-Daigneault Canada	9	132 0.5×	141 0.6×	75 0.7×	96 1.1×	43 1.3×	17	311
Yousef Ajlouni Jordan	7	168 0.7×	344 1.5×	31 0.3×	84 0.9×	13 0.4×	10	493
C. Bascietto Italy	7	283 1.1×	201 0.9×	96 1.0×	98 1.1×	22 0.7×	11	359

Countries citing papers authored by Stuart A. Becker

Since Specialization

Citations

This map shows the geographic impact of Stuart A. Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart A. Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart A. Becker more than expected).

Fields of papers citing papers by Stuart A. Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart A. Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart A. Becker. The network helps show where Stuart A. Becker may publish in the future.

Co-authorship network of co-authors of Stuart A. Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart A. Becker. A scholar is included among the top collaborators of Stuart A. Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart A. Becker. Stuart A. Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Dotan, Iris, Yulia Ron, Henit Yanai, et al.. (2014). Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 20(12). 2247–2259. 224 indexed citations

Dotan, Iris, Yulia Ron, Henit Yanai, et al.. (2013). Tu1145 Population Pharmacokinetic Evaluation of Infliximab Reveals Patient Factors That Increase Infliximab Clearance and Shorten Half-Life in Inflammatory Bowel Disease Patients. Gastroenterology. 144(5). S–774. 1 indexed citations

Becker, Stuart A., et al.. (2004). Brunner's gland hamartoma of the duodenum (Brunneroma).. PubMed. 6(11). 702–3. 3 indexed citations

Becker, Stuart A., et al.. (2002). Murine Monoclonal Anti-TNF Antibody Administration Has a Beneficial Effect on Inflammatory Bowel Disease That Develops in IL-10 Knockout Mice. Digestive Diseases and Sciences. 47(8). 1723–1727. 16 indexed citations

Becker, Stuart A., et al.. (2002). Hemoclip placement as definitive therapy for bleeding from a dieulafoy lesion.. PubMed. 4(8). 653–4. 6 indexed citations

Schuchmann, Marcus, et al.. (2000). Anti-TNF antibody administration has a beneficial effect on the inflammatory bowel disease that develops in IL-10 knockout mice. Gastroenterology. 118(4). A345–A345. 2 indexed citations

Schattner, Ami, et al.. (1999). Medline solution. The Lancet. 353(9151). 462–462. 6 indexed citations

Evron, Ella, et al.. (1995). Correlation between gold‐induced enterocolitis and the presence of the HLA‐DRB 1*0404 allele. Arthritis & Rheumatism. 38(6). 755–759. 9 indexed citations

Arber, Nadir, Zvi Fireman, Arnon Lavie, et al.. (1995). A Controlled Double Blind Multicenter Study of the Effectiveness of 5-Aminosalicylic Acid in Patients with Crohnʼs Disease in Remission. Journal of Clinical Gastroenterology. 20(3). 203–206. 47 indexed citations

10.

Geltner, David, et al.. (1986). Gold-Induced Ileitis. Journal of Clinical Gastroenterology. 8(2). 184–186. 7 indexed citations

11.

Becker, Stuart A., et al.. (1985). Crohn??s Ileitis Complicated by Amyloidosis: Observations and Therapeutic Considerations. Journal of Clinical Gastroenterology. 7(4). 296–300. 13 indexed citations

12.

Becker, Stuart A., et al.. (1981). Myopericarditis Associated with Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 3(3). 267–270. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact